Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
so when is the last day b4 EM? so I can time my entry for more
so the Indians are buying up the shares?
"Jeff said 8-k coming out before the 15th. He hinted we’ll find out in there why financials been delayed?"
OTCQB and OTCQX require that companies either register their securities with the SEC and have audited financial statements performed by a CPA audit firm that’s registered with the Public Company
So maybe they are looking to uplisting?
1. they are keeping the price low so they can buy more for lower price themselves
2. they are looking to sell the pipelines so they dont care if it goes to 0.1 or grey market.
OSA and Pain is the bread and butter, CX1739 is just a desert.
"We must complete a small pharmacokinetic and pharmacodynamic study with the new formulation of dronabinol before going on to Phase 3. The commencement of that study and the moving on to Phase 3 is contingent on having adequate finance and the success of the PK/PD studies. We do have a number of formulations that we can test, but have selected one as the lead and a few backups. We have already stated that we have a contract research organization and manufacturer in place who will begin the work, which has already been planned out and the work will commence once financing has been obtained. We have two commitments for finance, but need one more trigger to start bringing those funds in. "
bet alot of BP are eyeing KRM81: Purdue filed for Chapter 11 bankruptcy protection in September 2019. Scores of states, local governments, Native American tribes and victims had filed lawsuits against the company seeking damages arising from its manufacture and sale of OxyContin, which helped fuel the opioid epidemic
my estimate of market size:
OSA sleep-5B
OSA weight loss-150B
ADHD-5B
Spinal cord-5B
Epilepsy-9B
Pain-80B
as u can see the biggest market is weight loss and pain.
no less than $1 buyout and u know they want to sell theydont want to be pharm and have to manufacture drugs themselves
there is no way flow is 77M like most of us added together are already holding way more than 100M
yep buyout will be at $1-$10 range whocares about anything less than a penny movement
why is there a sticky post from some flipper not get taken out ?
be happy to get 10 billion buyout offer thats $10 a share
they tried to heep the price low so they can convert stock at lower price themselves
Series J Cumulative Redeemable Preferred Shares of beneficial interest, par value $0.01 per share.
someone leak good news? or ppl doing the clinic buying?
oh no running out of shares wtf where all these buyers come from? I was hopingto buy more at 0.00000008
when this thing hit $50 and u look back today u would careless if the price went from 0.007 to 0.001 I rather them sell some shares to help fund the research than doing reverse stock split.
why would they hire this guy if its not close to launch? https://www.proactiveinvestors.com/companies/news/1035802/respirerx-pharmaceuticals-makes-key-part-time-hire-to-drive-business-1035802.html
dont know when they started phase 3, the article stated they planned to finish phase 3 in 2019 and since there was a stock reverse in 2021 I am guessing they started phase 3 in 2022 so after 2 years 2024 is the end of phase 3?
I am guessing they are doing phase 3 now it got delayed b/c they didnt have the $$$ to start it?
"Â
For FDA approval and commercialization, a Phase 3 trial of dronabinol in OSA will be required. The clinical trial protocol will be written in conjunction with the clinical advisory panel and a licensing partner, however, some estimates of cost and time can be projected for budgeting and planning purposes. To that end, RespireRx estimates that the Phase 3 trial will require less than 300 patients at ~15 sites, and take approximately 24 months to complete, at a cost of roughly $12 - 14 million.
Â
Revenue Forecast
Â
The market potential for a new drug treatment for OSA is enormous, with a target market of nearly 20 million people in the U.S. alone. The original patent for the use of dronabinol for OSA is valid through 2025, so a Branded Generic Dronabinol at 80% of the price of current generic dronabinol products, and with only a maximum 10% market share, still achieves annual revenues exceeding $11 billion, as illustrated in Table 6."
https://www.sec.gov/Archives/edgar/data/849636/000149315217007695/ex99-4.htm
I am guessing the Dronabinol OSA is doing well in phase 2 thats why they entered manufacturing agreement It might even go straight to fast track approval without phase 3 otherwise why do they need manufacturing agreement?
how long will phase 2 takes?
good luck trying to buy large amount of shares lololololol
when is 120k loan due to be converted?
I wouldnt even buy 0.0001 once mm start dumping this will go down to 0.00005 or lower
Wrong Don the previous conversion was when the price was 5's now the price is 2's u are looking at 2.5 billions extra share to be dumped how much is this company worth when its 6 bilion shares? 0.00005?
maybe we should chip in to buy out the LOAN !
buy out 127k loan is the right thing to do or this stock will only be worth 0.0003 with 6 billion share out there
when does 127k notes get coverted? anyone know?
Back to 0.0003 again with no news
Back to 0.0003 better sell at 0.0005 now !!!
Back to 0.0003 dump @ 0.0005 now while u can !!!
Back to 0.0003 no more news for another 4 months. Better sell at 0.0005 now !!!
Lose another 50% after R/S better sell now b/c after R/S they might issue more shares u might lose another 50%
1,793,257,971 Held at DTC doesnt that means 1,793,257,971 will be added to the float or be given to someone for buyout offer? Now I can see why massive sell today ppl were afraid its going to be dilution coming.
why ppl selling if DTC is good?
what did Orphan said?